Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gryselda Hanafi"'
Autor:
Nina Dwi Putri, Aqila Sakina Zhafira, Pratama Wicaksana, Robert Sinto, Gryselda Hanafi, Lowilius Wiyono, Ari Prayitno, Mulya Rahma Karyanti, Murni Luciana Naibaho, Febrina Febrina, Hadyana Sukandar, Vivi Setiawaty, Mursinah Mursinah, Ahmat Rediansya Putra, Heri Wibowo, Julitasari Sundoro, Hindra Irawan Satari, Dwi Oktavia, Pretty Multihartina, Dante Saksono Harbuwono, Sri Rezeki Hadinegoro
Publikováno v:
Vaccines, Vol 12, Iss 4, p 344 (2024)
Coronavirus disease 2019 (COVID-19) has been extensively researched, particularly with regard to COVID-19 vaccines. However, issues with logistics and availability might cause delays in vaccination programs. Thus, the efficacy and safety of half-dose
Externí odkaz:
https://doaj.org/article/118810b60ef2425ebb31b2cea5148fcd
Publikováno v:
Paediatrica Indonesiana, Vol 62, Iss 4, Pp 243-8 (2022)
Background The prevalence of functional gastrointestinal disorders (FGIDs) is increasing among students in Indonesia. More adolescents came to the clinic with symptoms of functional constipation (FC), irritable bowel syndrome (IBS), and functional dy
Externí odkaz:
https://doaj.org/article/86c8d536303f4057967351b2ac1454ff
Autor:
Dominik F. Draxler, Gryselda Hanafi, Saffanah Zahra, Fiona McCutcheon, Heidi Ho, Charithani B. Keragala, Zikou Liu, David Daly, Thomas Painter, Sophia Wallace, Magdalena Plebanski, Paul S. Myles, Robert L. Medcalf
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-16 (2022)
Abstract Background Tranexamic acid (TXA) is an antifibrinolytic agent frequently used in elective surgery to reduce blood loss. We recently found it also acts as a potent immune-modulator in patients undergoing cardiac surgery. Methods Patients unde
Externí odkaz:
https://doaj.org/article/9acad31c0f7e4f36a4f5b7e6602bff63
Autor:
Antonius Hocky Pudjiadi, Nina Dwi Putri, Hikari Ambara Sjakti, Piprim Basarah Yanuarso, Hartono Gunardi, Rosalina Dewi Roeslani, Ade Djanwardi Pasaribu, Lies Dewi Nurmalia, Catharine Mayung Sambo, Lathiefatul Habibah, Indriyanti Natasya Ayu Utami, Yogi Prawira, Nastiti Kaswandani, Anggraini Alam, Kurniawan Taufiq Kadafi, Gryselda Hanafi, Angela Kimberly Tjahjadi, Shindy Claudya Aprianti, Nabila Maudy Salma, Stephanie Wijaya, Fatima Safira Alatas, Aman Bhakti Pulungan
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundAll sectors are affected due to COVID-19 pandemic occurring worldwide, including the education industry. School closure had been taking place for more than a year in Indonesia. Despite the controversies, Indonesian government had decided to
Externí odkaz:
https://doaj.org/article/c05a6c08d8db4f668e34fc23267935e2
Publikováno v:
Paediatrica Indonesiana. 62:243-8
Background The prevalence of functional gastrointestinal disorders (FGIDs) is increasing among students in Indonesia. More adolescents came to the clinic with symptoms of functional constipation (FC), irritable bowel syndrome (IBS), and functional dy
Publikováno v:
Archives of Pediatric Gastroenterology, Hepatology, and Nutrition. 1:17-27
Autoimmune hepatitis (AIH) is a condition caused by self-perpetuating immune response towards hepatocytes in liver. In children, AIH may progressed more rapidly compared to adults. Thus, early diagnosis and prompt treatment are the key for successful
Autor:
Saffanah Zahra, Paul S. Myles, Isaac Goncalves, Gryselda Hanafi, Huyen Tran, Anton Ilich, Heidi Ho, Charithani B. Keragala, Nigel S. Key, Dominik F. Draxler, Robert L. Medcalf
Publikováno v:
Blood Coagulation & Fibrinolysis. 32:172-179
Tranexamic acid (TXA) is a lysine analogue that inhibits plasmin generation and has been used for decades as an antifibrinolytic agent to reduce bleeding. Recent reports have indicated that TXA can paradoxically promote plasmin generation. Blood was
Autor:
Dominik F. Draxler, Gryselda Hanafi, Saffanah Zahra, Fiona McCutcheon, Heidi Ho, Charithani B. Keragala, Zikou Liu, David Daly, Thomas Painter, Sophia Wallace, Magdalena Plebanski, Paul S. Myles, Robert L. Medcalf
Publikováno v:
Thrombosis journal. 20(1)
Background Tranexamic acid (TXA) is an antifibrinolytic agent frequently used in elective surgery to reduce blood loss. We recently found it also acts as a potent immune-modulator in patients undergoing cardiac surgery. Methods Patients undergoing lo
Autor:
Heidi Ho, Dominik F. Draxler, Antoine Roquilly, Dena Lyras, Milena M. Awad, Robert L. Medcalf, Gryselda Hanafi, Charithani B. Keragala, Maithili Sashindranath, Adam Galle, Maria Daglas
Publikováno v:
Journal of neurotrauma. 36(23)
The antifibrinolytic agent, tranexamic acid (TXA), an inhibitor of plasmin formation, currently is evaluated to reduce bleeding in various conditions, including traumatic brain injury (TBI). Because plasmin is implicated in inflammation and immunity,
Autor:
Fiona McCutcheon, Julia L. Gregory, Charithani B. Keragala, Dominik F. Draxler, Gryselda Hanafi, Amanda E. Au, Anushka Fernando, David W. Wright, Heidi Ho, Magdalena Plebanski, Robert L. Medcalf, Pia Larsson, Maria Daglas, Be'eri Niego, Maithili Sashindranath, Kirsty Wilson, Adam Galle, Elnaz Tavancheh
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 17(12)
Background Traumatic brain injury (TBI) is known to promote immunosuppression, making patients more susceptible to infection, yet potentially exerting protective effects by inhibiting central nervous system (CNS) reactivity. Plasmin, the effector pro